Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Other financing activities (2020 - 2023)

Cellectis (CLLS) posted quarterly Other financing activities of $1.3 million for Q2 2023, up 417.16% year-over-year from $246536.8 in Q2 2022, and up 151.98% quarter-over-quarter from $506000.0 in Q1 2023.

Analysis

Cellectis (CLLS) Other financing activities (2020 - 2023) Analysis & Trends

Cellectis' Other financing activities history runs 4 years deep, the most recent figure standing at $1.3 million for Q2 2023.

  • In Q2 2023, Other financing activities rose 417.16% year-over-year to $1.3 million; the TTM figure through Sep 2023 stood at $478000.0 (down 94.58% YoY), while the FY2015 annual figure was $349.1 million, up 133.73% from the prior year.
  • Other financing activities for Q2 2023 stood at $1.3 million, up from $506000.0 in the prior quarter.
  • The five-year high for Other financing activities was $11.8 million in Q1 2021, with the low at -$1.3 million in Q3 2022.
  • The 4-year median for Other financing activities is $269000.0 (2020), against an average of $2.8 million.
  • The sharpest annual moves came in 2022 and 2023: Other financing activities tumbled 1397.7% in 2022, then jumped 417.16% in 2023.
  • Cellectis' Other financing activities stood at $32000.0 in 2020, then slumped by 371.88% to -$87000.0 in 2021, then sank by 1397.7% to -$1.3 million in 2022, then jumped by 197.85% to $1.3 million in 2023.
  • Business Quant data shows CLLS's Other financing activities at $1.3 million in Q2 2023, $506000.0 in Q1 2023, and -$1.3 million in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.28 Mn
Mar 31, 2023 506,000.00
Dec 31, 2022 -254,000.00
Sep 30, 2022 -1.30 Mn
Jun 30, 2022 -402,000.00
Mar 31, 2022 10.61 Mn
Dec 31, 2021 -130,000.00
Sep 30, 2021 -87,000.00
Mar 31, 2021 11.82 Mn
Dec 31, 2020 133,000.00
Sep 30, 2020 32,000.00